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An increase in microcephaly, associated with an epidemic of Zika
virus (ZIKV) in Brazil, prompted the World Health Organization
to declare a Public Health Emergency of International Concern
in Feb/2016. While knowledge on biological and epidemiologi-
cal aspects of ZIKV has advanced, demographic impacts remain
poorly understood. This study uses time series analysis to assess
the impact of ZIKV on births. Data on births, fetal deaths, and
hospitalizations due to abortion complications, for each Brazil-
ian state, from 2010-2016, were used. Forecasts for Sept/2015-
Dec/2016 showed that 119,095 fewer births than expected were
observed, particularly after Apr/2016, demonstrating a link be-
tween publicity associated with ZIKV and decline in births. No
signiﬁcant changes were observed in fetal death rates. Although
no signiﬁcant increases in hospitalizations were forecasted, after
the ZIKV and microcephaly outbreaks hospitalizations happened
earlier in the gestational period in more than half of the Brazilian
states. We argue that postponement of pregnancy and an increase
in abortions contributed to the decline in births after Apr/2016.
Also, it is likely that an increase in safe abortions happened,
albeit selective by socioeconomic status. Thus, the ZIKV epidemic
resulted in a generation of congenital Zika syndrome (CZS) babies
that reﬂect and exacerbate regional and social inequalities. Since
ZIKV transmission has declined, it is unlikely that reductions in
births will continue. But the possibility of a new epidemic is
real. There is a need to address gaps in reproductive health and
rights, and to understand the risk of CZS in order to better inform
conception decisions.
Zika Virus j Congenital Zika Syndrome j Brazil j Births j Abortion
Since late 2014, reports of a new exanthematic disease were
issued in the Northeast region of Brazil. In early 2015, an out-
break of Zika virus (ZIKV – an arbovirus) was reported in
the region, following a probable introduction in 2013 (1-3). By
October 2015, an unusual increase in microcephaly cases among
infants occurred in this region, and a possible association with
ZIKV was suggested (2, 4, 5). As microcephaly cases increased
steadily, the Brazilian Ministry of Health declared a state of
health emergency in November 2015, the Pan American Health
Organization (PAHO) issued an epidemiologic alert regarding
ZIKV in Latin America on the same month, and on February 1,
2016, the World Health Organization (WHO) declared clusters
of microcephaly cases and other neurological disorders reported
in Brazil as a Public Health Emergency of International Concern
(PHEIC) (6). The PHEIC was lifted on November 18, and while
worldwide public attention has waned since then (7), the WHO
included ZIKV as one of the priority diseases for action to
prevent epidemics (8). In May 11, 2017, Brazil lifted the state of
emergency.
Evidence of a causal link between ZIKV and microcephaly
steadily accumulated since November 2015 (2, 9-14), and was
formally accepted in April 2016 (15-17). Yet, microcephaly is just
one of the many ZIKV-related birth complications, now referred
to as congenital Zika syndrome (CZS) (18). About 20% of the
children born with CZS have normal head sizes (19), and children
born without any abnormality were later found to have developed
brain damage and developmental problems (20). In addition,
ZIKV infections during any trimester of pregnancy may result in
CZS, even if asymptomatic (21).
The number of ZIKV cases observed in Brazil since the
2015 outbreak carries much uncertainty. Mandatory notification
of ZIKV commenced in February 2016, however, some of the
reported ZIKV cases were not confirmed, and misdiagnoses
between dengue, ZIKV, and chikungunya might have occurred
early in the epidemic. Also, accurate diagnosis with laboratory
tests was challenging due to the short viremia period, and to cross-
reactivity among dengue and ZIKV in serodiagnostics (22, 23). A
recent analysis of suspected urban arboviruses reported in 2015
and 2016 suggests that 1,673,272 ZIKV cases occurred in 2015
and 2016, 41,473 (2.5%) of them among pregnant women (24).
Two waves of ZIKV infection (and thus of ZIKV infection during
pregnancy) were observed in all regions in Brazil: the first in 2015
(March to July), and the second from September 2015 to August
2016 (24).
As for CZS, 2,751 cases have been confirmed from 2015 to
2017 (as of August 26, 2017). Although autochthonous trans-
mission of ZIKV was confirmed in all Brazilian states, the ge-
ographical distribution of CZS cases was not uniform (Fig. 1).
The Northeast region bore the heaviest burden, 69.5% of all CZS
cases, although only 15.4% of the confirmed and 26.6% of the
suspected ZIKV cases among pregnant women were recorded
in that region. The peak in CZS per 10,000 live births in the
Northeast was observed in December 2015 (56.7), but only in
August 2016, and at much lower levels, in the North, Center-
West, and Southeast regions (7.8, 15.4, and 5.5, respectively).
Between 2015 and 2017 there were 86.1 CZS cases per 1,000
pregnant women with a suspected ZIKV infection, ranging from
Signiﬁcance
Zika virus (ZIKV) was discovered 70 years ago, and since then
small isolated outbreaks occurredwithoutmajor complications
being reported. When ZIKV hit Brazil, however, a public health
emergency was declared given its link with microcephaly.
Knowledge on ZIKV has advanced, but demographic impacts
remain poorly understood. This study uses data from Brazil
to assess whether a decline in births occurred after the onset
of ZIKV. Forecasts show signiﬁcant birth declines, particularly
after Apr/2016. No signiﬁcant changes in fetal death rates,
and no pattern of increase in hospitalizations due to abor-
tion complications were observed, although hospitalizations
occurred later in some states. We argue that postponement
of pregnancy and abortions, primarily, likely affected fertility,
with implications for women’s reproductive health.
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Fig. 1. Conﬁrmed Congenital Zika Syndrome (CZS) cases from 2015 to 2018
(as of March 3, 2018), by state. States with 100 or more CZS cases ranked
among the top ten. Starting from the southern portion of the map, the
regional division is as follows: South – Paraná (PR), Santa Catarina (SC), and
Rio Grande do Sul (RS); Southeast – Espírito Santo (ES), Minas Gerais (MG), Rio
de Janeiro (RJ), and São Paulo (SP); Center-West – Goiás (GO), Mato Grosso
do Sul (MS), Mato Grosso (MT), and Distrito Federal (DF); Northeast –Alagoas
(AL), Bahia (BA), Ceará (CE), Maranhão (MA), Paraíba (PB), Pernambuco (PE),
Piauí (PI), Rio Grande do Norte (RN), and Sergipe (SE); and North – Acre (AC),
Amapá (AP), Amazonas (AM), Pará (PA), Roraima (RR), Rondônia (RO), and
Tocantins (TO).
6.1 in Paraná state (South region) to 758.8 in Paraíba (Northeast
region) (24). Cases have waned since May 2016, and of the total
confirmed CZS cases since 2015, only 76 were born in 2017 (as of
August 26).
The link between ZIKV and microcephaly spurred some
government leaders in Latin America to suggest that women
should postpone having babies for a few years (25), ignoring the
fact that, in the region, more than half of the pregnancies are not
intended (26); rates of sexual violence are high (27); and while
abortion is heavily legally restricted, women seek clandestine
abortions, or self-induce the termination of pregnancy, mostly
under unsafe conditions (28). In Brazil, for example, abortion
is only allowed to save a woman’s life or in cases of rape. Yet,
according to the 2013 National Health Survey, an estimated 1.1
million induced abortions were practiced by women aged 18-49,
39%of them in theNortheast region (whereZIKVand associated
CZS hit the hardest) (29). Women of low socioeconomic status
are those most often exposed to an unsafe procedure and to its
harmful consequences (30). It is estimated that about half of the
women who undergo an induced abortion require hospitalization
due to complications following the procedure (30, 31), a concern
for women’s reproductive health and rights. In the absence of a
treatment that prevents ZIKV from crossing the placenta, and
of a legal abortion policy, women have no legal framework to
exercise the choice of continuing or terminating a pregnancy
following a ZIKV infection and an ultrasound showing problems
in fetal development; she would have to carry on the pregnancy
and face the risk of delivering a child with congenital problems,
or put her own health at risk by inducing an abortion (25).
In such a scenario, we hypothesize that the ZIKV epidemic
could have led to reductions in the number of live births due to
three reasons: (i) an above average fetal death rate following a
ZIKV infection during pregnancy; (ii) couples/women who want
to become pregnant may decide to postpone pregnancy based
on their perception of risk of having a child with congenital
malformations; and (iii) couples/women choose to terminate the
pregnancy given a confirmed or suspected malformation of the
fetus following a ZIKV infection. With regards to fetal death,
current evidence of higher rates among pregnant women who had
a ZIKV infection, based on cohort studies of pregnant women is
conflicting (21, 32, 33). Also, preliminary results from different
surveys conducted in 2016 suggest that women were postponing
pregnancy to avoid ZIKV-related birth defects (34, 35). As for
abortions, there is evidence that the demand for abortionmedica-
tions (mifepristone and misoprostol) has increased substantially
in Brazil after the onset of the ZIKV epidemic (36). In the
case of an elective pregnancy termination, the ZIKV outbreak
could affect the timing of the procedure, with implications for
women’s health. On the one hand, couples/womenmay opt for an
abortion very early in the gestation after a confirmed or suspected
ZIKV infection, and/or widespread panic and misinformation
that exacerbates the perception of risk, particularly in the initial
phase of the epidemic. On the other hand, couples/women may
opt to have an abortion late in the gestational period after a fetal
malformation is detected through ultrasound examination.
We also postulate that the causes of reductions in the number
of births vary by time (SI Appendix, Fig. S1). First, we consider
an acute phase when the cases of CZS are on the rise, and when
the novelty of the disease as well as its congenital effects get
constant attention in the media (e.g., radio, TV, billboards, social
networks). During this phase, observedCZS cases were conceived
before the association between ZIKV and microcephaly was
suspected. Therefore, we assume that any changes in the number
of live births during this phase could result only from above
average fetal deaths and abortions, since couples/women con-
ceived before the harmful consequences of ZIKV became known.
Second, we consider a transition phase when ZIKV cases are
declining, but couples’/women’s perception regarding the risk of
having a child with CZS is still very high, followed by a third phase
when ZIKV remains endemic but with very low transmission, and
thus with a small number of CZS cases recorded. During the
second and third phases, declines in the number of live births
could result from any of the three reasons hypothesized above.
Geographically, we expect that any changes in births due to ZIKV
would be widespread early in the epidemic, becoming more focal
as cases decline (SI Appendix, Fig. S1).
In this study, by integrating subnational (state-level) and
monthly data on births, fetal deaths, abortion-related hospital-
izations, and female population aged 10-49 years we assessed
whether a significant decline in the number of live births was
observed after Aug/2015, and whether the magnitude of the
decline varied over time and across states. We also investigated
whether significant changes were observed in fetal death rates,
and assessed if the cross-correlation between births and hospital-
izations due to abortion complications changed after Aug/2015.
Since the geographical distribution of ZIKV and CZS were not
homogeneous (Fig. 1), we assessed if reductions in the number
of live births were concentrated in areas mostly affected by the
epidemic.
Results
Time series of monthly births, fetal deaths, and hospital admis-
sions of women due to abortion complications were extracted
from administrative databases from 2010 to 2016, and forecasts
of the general fertility rate (GFR), of the fetal death rate, and
of the rate of hospitalizations due to abortion were calculated
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Fig. 2. Observed and forecasted monthly live births, Sept/2015 to Dec/2016. Forecast based on ARIMAmodels ﬁt to the general fertility rate; forecasted GFRs
were converted into number of live births considering the female population aged 10-49 years (Materials and Methods). Grey area in the graphs corresponds
to the 95% conﬁdence interval of the forecast. Graphs show the states that compose the Northeast region, the total for the Northeast region, and the total
for the remaining states in Brazil.
for the period from Sept/2015 to Dec/2016 (Materials and Meth-
ods). A total of 3,820,304 births were reported in Brazil from
Sept/2015 to Dec/2016, while our analysis forecasted 3,998,216
births (SI Appendix, Table S1). However, the difference between
forecasted and reported births was within the 95% confidence
interval in Sept/2015-Jul/2016 (SI Appendix, Table S2). During all
other months of the forecasted period, the difference amounted
to 119,065 births. Thus, for every 100 births registered in Brazil in
2016, 4.2 were forecasted but not observed.
Individual state forecasts showed that, among the nine states
of the Northeast region, only in Ceará and Piauí the observed
number of births fell inside of the forecasted confidence interval
(Fig. 2). At a 5% significance level, the states in the Northeast
region had 36,546 fewer births than expected, all in 2016 (SI Ap-
pendix, Table S2). The deficit in births had important geographical
differences. In Paraíba, for every 100 births observed in 2016, 5.7
were forecasted but not observed; in Pernambuco and Rio de
Janeiro these figures were 8.8 and 7.2, respectively, while in Bahia
it was only 1.8. Regionally, this ratio was 4.6 for the Northeast,
5.3 for the Southeast, and 2.3 for the North. The correlation
coefficient between the deficit in live births and CZS cases by
state was 0.64 for the states in the Northeast region, and 0.36 for
all states but those in theNortheast region (none significant at the
5% level). Weighted linear regression between the two variables
(with women aged 10-49 years in 2016 as the weights) showed no
significant effects (SI Appendix, Fig. S2 and Table S3).
From Sept/2015 to Dec/2016, 257,645 hospital admissions
due to abortion complications were reported in Brazil, while
our model forecasted 274,615 during the same period; of this
difference, only 5,986 were significant (SI Appendix, Fig. S3).
Individual state forecast indicated a pattern of fewer hospitaliza-
tions in several states, particularly in the Northeast and Southeast
regions in 2016 (SI Appendix, Table S4). The cross-correlation (SI
Appendix) between births and hospitalizations due to abortion
complications pointed to significant changes in the time lag (SI
Appendix, Table S5). Specifically, considering the data for Brazil,
while in the period Jan/2010-Aug/2015 hospitalizations due to
abortion complications were correlated with live births seven
months afterwards, in the period Sept/2015-Dec/2016 the time lag
decreased to six months. This pattern of later hospitalizations in
the gestational period was observed in 14 states, with time lags
changing from seven to six months in 11 states, from six to five
months in two states, and from seven to five months in one state.
All regions observed changes, except the North.
Time series analysis of fetal death rates indicated no signifi-
cant changes for Brazil, regions and states. For Brazil, rates were
consistently around 11 deaths per 1,000 live births. Since the year
2000, fetal death rates were consistently higher in the Northeast
region (around 13 per 1,000 live births), a pattern that remained
the same after the onset of the ZIKV epidemic. Bahia, the state
with the largest number of CZS cases, regularly recorded the
highest fetal death rates (around 15 per 1,000 live births) (SI
Appendix, Table S6).
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Discussion
This study provides a comprehensive analysis of the impact of
ZIKV on live births in Brazil. Our analysis was based on monthly
data from Jan/2010 to Dec/2016 for Brazil and for each of the 26
states and the federal district. Forecasts of theGFR for the period
from Sept/2015 to Dec/2016 demonstrated that fewer births than
expected were observed after the emergence of ZIKV in Brazil.
Despite the decline in births, no significant increases in fetal
death rates were observed, and hospitalizations due to abortion
complications were fewer than expected. However, our results
show that hospitalizations happened at later gestational ages after
the ZIKV and microcephaly outbreaks.
Guided by our proposed framework (SI Appendix, Fig. S1),
our results demonstrate that postponement of pregnancy may
have contributed to the decline in births after Apr/2016. These
findings are supported by a survey conducted in all capital cities
of the Northeast region betweenMarch 30th and June 3rd of 2016,
which showed that about 18% of the women using contraception
did so because of the ZIKV epidemic (34). Fetal deaths did not
seem to have played a major role, corroborating findings of a
cohort study of women in Rio de Janeiro (21). Also, the fact
that hospitalizations due to abortion complications were fewer
than expected cannot rule out a possible increase in abortions.
All pregnancy terminations that were conducted safely would not
result in a hospitalization, and thus would not be captured by
routine administrative data collection. Indeed, a large increase in
online requests for abortion medications in Brazil was reported
between Nov/2015 and Mar/2016 – after PAHO issued an epi-
demiological alert (36), and drug-induced abortions carry a very
small risk of complications (37). As for the spatial extent of the
birth declines, our results indicate that after April 2016 they were
not as concentrated in the ZIKV hardest hit areas as we initially
hypothesized.
We urge caution in the interpretation of these results, as well
as on any attempt to assess declines in births due to ZIKV. By no
means should one claim that all declines in births were a result
of the ZIKV outbreak, and we offer four reasons why. First,
economic crises can affect the decision to have a child (38-40),
and since January 2015 unemployment rates in Brazil have been
increasing; the annual average unemployment rate was 8.5, 11.5,
and 12.7 in 2015, 2016, and 2017, respectively, reaching a peak of
13.7 in March 2017 (41). Second, current legislation states that
births should be reported up to 60 days after birth. However,
longer lag periods may occur, in which case the use of incomplete
data would bias the analysis (more specifically, overestimate the
difference between forecasted and observed births). We limited
our analysis to births reported until Dec/2016, since later data
were still incomplete. Thus, although a few events in the studied
period may be missing, we expect this number to be small and
thus to not change our results. Third, the quality (completeness
and accuracy) of administrative data varies (Materials and Meth-
ods). However, given the increased attention to track pregnancies
and births for CZS, particularly during the peak of the ZIKV
epidemic, it is expected that, at that time, underreporting was
lower than usual. Lastly, part of the decline may result from lower
desired fertility (irrespective of ZIKV). However, based on the
Brazilian experience (42), it is unlikely that this factor alone may
account for the observed deficit in births during the forecasted
period.
Our results raise five important questions. First, will the
decline persist over time and affect the total fertility rate (TFR)?
Fertility in Brazil has rapidly declined since the 1960s, across all
socioeconomic strata, and in 2010 the TFR was 1.9, below re-
placement level (43). Approximately 3million births are observed
annually, 39% in the Southeast region - home to megacities such
as São Paulo and Rio de Janeiro, and 28% in the Northeast.
We argue that since ZIKV transmission has declined, and the
attention has waned, it is unlikely that reductions in births will
persist over time. Instead, we expect that the decline in births
will characterize a tempo distortion in period fertility (44). While
this could be an issue for women in the older age range of the
reproductive period, only 13% of the fertility rate in Brazil is
concentrated above age 35.
Second, was there an increase in seeking behavior for a safe
abortion? There are no systematic data to answer this question.
Safe procedures, either medical or surgical, can only be estimated
through self-reported surveys. In addition, unsafe procedures that
result in hospitalizations could be underreported to protect the
woman or the doctor from legal complications. However, our
results revealed significant declines in hospitalizations due to
abortion complications in several states, which could suggest that
safer procedures were sought. Data showing a spike on requests
for abortion medications suggest an increase in safe procedures
following the ZIKV epidemic (36). This question needs to be
reassessed and quantified based on indirect estimates (45) and
special surveys.
Third, was there a selection in who decided to perform an
abortion? About 83% of women who had a child with CZS
in Brazil were non-whites (24), whereas 49.7% of the female
Brazilian population is non-white (in Brazil, the standard racial
categories are white, black, brown, yellow, and indigenous). In
the absence of selective abortion and contraception, this would
only be possible if non-whites were under a higher risk of a
ZIKV infection. Although poor housing conditions, precarious
infrastructure, and low socioeconomic status are factors often as-
sociated with higher transmission of Ae. Aegypti-related diseases
(46), health care provided by the private sector is largely underre-
ported in the Brazilian National Notifiable Diseases Information
System (SINAN), despite the fact that notification is mandatory
(47). This sub-notification, however, cannot explain the racial
difference in mothers who had babies with CZS since the birth
registration system captures vital events irrespective of delivery
location. Also, the use of contraception in Brazil is high (around
80%), irrespective of region and race (48). Therefore, we argue
that the higher percentage of babies with CZS born to non-white
mothers reflects a lower number of safe abortions among non-
whites. As a result, the ZIKV epidemic resulted in a generation of
CZS babies that reflect and exacerbate well documented regional
and social inequalities in Brazil (49).
Fourth, are there specific factors prevalent in the Northeast
region or among certain populations that increased the severity of
ZIKV during pregnancy? It is possible that the observed burden
of CZS in the Northeast and among the non-white population is
not solely a result of differentiated use of abortion and contracep-
tion, but of other conditions that could alter the risk of a ZIKV in-
fection.While this issue is being investigated by different research
groups, currently there is no evidence that such factors exist. Also,
although some cases of CZS complications only manifest later in
infancy (20, 50), it is unlikely that those babies are predominately
outside the Northeast.
Fifth, in the absence of a vaccine, are there ideal temporal
windows of conception to minimize the risk of CZS? Birth sea-
sonality is observed in most human populations (51). In Brazil,
the peak of births consistently occurs between March and May,
corresponding to conceptions during the winter months of June
to August, and a secondary peak is observed in September
(conceptions in December); the valley happens from October
to December, associated with conceptions during the summer
months of January to March (52). Similarly, ZIKV transmission
follows a seasonal pattern common to arboviruses, with peaks
usually observed during warmer and wetter months (53), which
in Brazil ranges from December to April. Thus, the peak of
conception coincides with the low transmission season of ZIKV,
but part of the second and all third trimester would overlap the
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favorable months for Ae. Aegypti. In contrast, conceptions during
the summer months expose the pregnant woman to an infection
in the first trimester, part of the second, and the later part of the
third. That pattern is reflected on the curves of CZS per 10,000
births, where peaks were observed in November for Brazil, and in
December for the Northeast region (24). As a result, the months
when fewer births are often observed were those with higher risk
of delivering a baby with CZS, given a higher exposure to ZIKV
during conception. Although ZIKV transmission in Brazil has
been drastically reduced, a new wave of transmission is possible.
Therefore, a comprehensive modeling of CZS risk by gestation
month of infection to devise potential temporal windows for
conception that minimize the burden of fetal complications is
needed.
Although we cannot disentangle the causes of the decline in
live births reported in our analysis, we argue that both abortions
and pregnancy postponement were important, with crucial
differences by state and some population groups that reflect
social inequalities in Brazil. The possibility that pregnancies
were intentionally terminated (and some performed later in
the gestational period), particularly when the link between
ZIKV and microcephaly got attention in the media, raise
concerns about reproductive women’s health and rights. The
most recent evaluation of abortion safety estimated that 45.1%
of worldwide abortions performed in the period 2010-2014
were unsafe; in South America this number was 75.1% (54).
This issue has been heavily debated in Brazil, and in Sept/2016,
the National Prosecutor publicly expressed his support for
abortion for pregnant women infected with ZIKV, since the
continuation of pregnancy could not only result in CZS, but
also compromise the mental health status of the mother
(http://agenciabrasil.ebc.com.br/geral/noticia/2016-09/em-
parecer-janot-defende-aborto-para-gravidas-com-virus-zika).
However, no legislation change has happened yet.
Though the incidence of ZIKV cases has declined, the threat
is not gone. Ae. Aegypti reigns in Brazilian cities, and currently
transmits dengue, Zika, chikungunya, Mayaro virus, and, is com-
petent to transmit the strains of the virus circulating in the
country (55) – indeed, in 2018 urban yellow fever was recorded
in Brazil, 76 years after urban transmission had been successfully
eliminated. A new epidemic of ZIKV is possible, and could be
exacerbated by climatic conditions (56, 57). On the one hand,
vector control efforts do need to be strengthened, involving
the collaboration of different sectors of the government in an
effort to address challenges of the urban landscape that favor
the proliferation of mosquito breeding habitats (e.g., regular
access to water and waste collection). On the other hand, the
health and social consequences of the 2015-16 ZIKV epidemic in
Brazil should motivate strategies that properly address women’s
reproductive health and rights, ranging from communication to
access to contraception and safe abortion. Failure to do either
will result in further generations of CZS babies, disproportionally
affecting the poor. Time will tell.
Materials and Methods
Data collection. We assembled a monthly time series of live births from
Jan/2010 to Dec/2016, for each one of the 26 Brazilian states and for the
federal district, from the Information System on Live Births (SINASC) of the
Ministry of Health. Records of births after Dec/2016 were still incomplete
and thus not included in the analysis. SINASC records live births from birth
certiﬁcates; by law, the certiﬁcate should be issued at the health facility
where the baby was delivered, or at a Public Civil Registry when the baby
is delivered at home (less than 3% of births in Brazil are delivered at home)
(58). Monthly GFR (considering the number of women aged 10-49 years in
the denominator) were calculated for each state. Although underreporting
of vital events still occurs (59), it is estimated that SINASC covers more than
96% of all births in the country (60).
Since abortion is heavily legally restricted in Brazil, comprehensive and
reliable data are not available, except from special surveys. As a proxy, we
used a monthly time series of hospital admissions of women due to abortion
complications between 2010 and 2016, for each one of the 26 Brazilian
states and for the federal district, obtained from the Hospital Information
System of the Ministry of Health (SIS-SUS). The data consider codes O00-O08
(pregnancy with abortive outcome) of the 10th Revision of the International
Statistical Classiﬁcation of Diseases and Related Health Problems (ICD-10).
Although this information only refers to complications (and therefore does
not capture safely induced medical or surgical abortions), changes in the
pattern of these data may suggest that either spontaneous or induced
abortions deviated from expected behavior. Monthly rates of hospitalization
per 10,000 women ages 10-49 years were calculated for each state. Although
there is no comprehensive study on the quality of SIS-SUS, the data only
cover hospitalizations funded by the National Health Service, about 70-80%
of the total number of admissions, and there is some evidence that both
underreporting and misclassiﬁcation occur (61).
Data on fetal deaths per month were obtained from the Mortality
Information System (SIM) of the Ministry of Health, for the period Jan/2010
to Dec/2016. Here, a fetal death was deﬁned in accordance with the ICD-
10: “death prior to the complete expulsion or extraction from its mother
of a product of conception...the fetus does not breathe or show any other
evidence of life, such as beating of the heart, pulsation of the umbilical
cord, or deﬁnitemovement of voluntarymuscles” (62). More speciﬁcally, data
include death of fetuses with 22 or more gestational weeks, or birthweight
of 500g or more, or crown-heel length of 25cm or more (63). Monthly rates
f fetal deaths per 1,000 live births were calculated for each state. Analogous
to SINASC, despite some underreporting, the coverage of SIM is about 96%
(64).
Seasonal differencing. Human birth seasonality is a common phe-
nomenon in most populations (65, 66). In Brazil, peaks in births are observed
between March and May, with a secondary peak in September (52). This
pattern is the same across regions, and socioeconomic status of the mother
(52). To account for the seasonal effect, we analyzed the auto-correlation
function (ACF) of the original data and the data after seasonal differencing;
at lag 12 the ACF was high for the original time series and not signiﬁcant
after seasonal differencing. Therefore, we considered a seasonal effect of
order 12 ( , where is the record formonth t) before applying
Auto Regressive Integrated Moving Average (ARIMA) models.
ARIMA models. We ﬁt ARIMA(p ,q, d)(P, Q, D)m models to the time
series of GFR, fetal death rates, and rates of hospitalizations due to abortion
complications, separately for each of the 27 states and for the country
total (a total of 28 models), after taking seasonal differencing. The seasonal
differencing usedD=1,m=12. We checked the autocorrelation and identiﬁed
D=1, m=12 as appropriate, and D=2, m=12 as not necessary, so the models
are of the form (p,q,d)(0,0,1)12. We used the function auto.arima from R
package 'forecast'. The parameters (p, d, q) were determined by the function
through model selection criteria using Bayesian information criterion (BIC).
Here p is the order of autoregression, d is the degree of ﬁrst differencing, and
q is the order ofmoving average.We utilized data from Jan/2010 toAug/2015
to generate out-of-sample monthly forecasts for the period Sept/2015 to
Dec/2016, and the respective 95% conﬁdence intervals. Forecasted GFR was
converted into number of births based on the female population aged 10-49
years. Monthly forecasts were comparedwith observed values recorded since
Sept/2015, in order to quantify any signiﬁcant changes, and to assess if/how
these changes differed across states and over time. Observed values that
were outside the forecast conﬁdence interval were considered as signiﬁcant
changes.
Cross-correlation. We calculated cross-correlation functions between
the time series of births and hospitalizations due to abortion complications
to identify the time lag that maximizes the correlation between the two
series, which is an indication of the timing of abortions (SI Appendix). For
the purpose of assessing whether changes in the timing of abortions were
observed after the onset of ZIKV, we considered two time periods. First, we
used Jan/2010 to Aug/2015, prior to the massive attention given to ZIKV in
the media. Second, we used Sept/2015 to Dec/2016, when awareness of the
congenital effects of ZIKV was widespread.
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